Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Biogen, Charge, Fastly, and NIKE and Encourages Investors to Contact the Firm

Go back to Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Biogen, Charge, Fastly, and NIKE and Encourages Investors to Contact the Firm

Nike (NKE) PT Lowered to $92 at Deutsche Bank

July 3, 2024 5:17 AM EDT

Deutsche Bank analyst Krisztina Katai lowered the price target on Nike (NYSE: NKE) to $92.00 (from $115.00) while maintaining a Buy rating.

The analyst comments "We approached NKE's turnaround acknowledging that patience will be required. 4Q's results and the steeper-than-expected FY25 sales revision showcased that... More